Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
BMC Pulmonary Medicine|December 8, 2007
Features of asthma management: quantifying the patient perspectiveJohn Haughney, Monica Fletcher, Stephanie Wolfe, et al.
International Journal of Toxicology|July 31, 2026
Structure-Dependent Cytotoxicity of Environmentally Relevant Benzothiazole Derivatives Across Human Cell ModelsStephanie Wolfe, Tasniyah Nayaz, Alisha Janiga-MacNelly, et al.
BMJ (Clinical Research Ed.)|March 1, 2003
Accessibility, acceptability, and effectiveness in primary care of routine telephone review of asthma: pragmatic, randomised controlled trialHilary Pinnock, Robert Bawden, Stephen Proctor, et al.
Bioorganic & Medicinal Chemistry Letters|April 4, 2006
Rediscovery of natural products using genomic toolsAkira Kawamura, Angelika Brekman, Yevgeniy Grigoryev, et al.
Respiratory Medicine|July 23, 2017
Initiating or changing to a fixed-dose combination of Fluticasone propionate/Formoterol over Fluticasone propionate/Salmeterol: A real-life effectiveness and cost impact evaluationSimon Wan Yau Ming, John Haughney, Iain Small, et al.
Pharmacoeconomics|June 17, 2010
Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trialEdward C F Wilson, Erika J Sims, Stanley D Musgrave, et al.
Pharmacoeconomics|May 8, 2010
Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trialEdward C F Wilson, David Price, Stanley D Musgrave, et al.
The New England Journal of Medicine|May 6, 2011
Leukotriene antagonists as first-line or add-on asthma-controller therapyDavid Price, Stanley D Musgrave, Lee Shepstone, et al.
Pageof 1